-
Zimmer Biomet's 2024 growth strategy
Zimmer Biomet outlined a three-year plan to bring above-market growth by the end of 2027. -
Canary Medical's smart spinal fusion implant earns FDA breakthrough designation
Canary Medical earned the FDA's breakthrough designation for its smart lumbar spine cartridge, the devicemaker said May 29. -
Vuze Medical gets FDA clearance for 2nd generation spine software
Vuze Medical's software-based 3D spine guidance earned FDA 510(k) clearance for its second iteration, the company said May 29. -
7 spine devices earning FDA approval in 45 days
Here are seven spine devices that have received FDA clearance that Becker's has reported on since April 16: -
Spineart gains FDA clearance for anterior cervical cage
Spineart received FDA 510(k) clearance for its SCARLET AC-Ti secured anterior cervical cage. -
Medtronic's fiscal year 2024 and Q4 sales grow, net earnings dip: 7 notes
Medtronic in the fourth quarter of fiscal year 2024 saw $8.6 billion in revenue along with a net income of $654 million, according to financial results posted May 23. -
Orthofix names global spine president
Orthofix named Max Reinhardt as president of global spine effective June 10, the devicemaker said May 23. -
4 medtech notes: Medtronic, Accelus and more
From leadership moves to FDA nods, here are four key updates from spine and orthopedic devicemakers since May 15. -
Kevin Lobo 10th highest-paid healthcare CEO: WSJ
Stryker CEO Kevin Lobo is the 10th-highest paid healthcare CEO, according to The Wall Street Journal. -
Meet the CFOs of 5 spine devicemakers
Here are the executives overseeing finances at five spine devicemakers: -
Meet the CEOs of 5 spine device companies
Here are the CEOs of five spine device companies worldwide: -
Accelus names new vice president of regulatory and quality
Accelus named Chris McKee as vice president of regulatory and quality, the devicemaker said May 16. -
Medtronic continues restructuring, layoffs
Medtronic has laid off more staff as part of ongoing restructuring, a spokesperson for the devicemaker told Becker's. -
5 medtech notes: Orthofix, Aurora Spine and more
Here are five key updates from spine and orthopedic devicemakers since May 8: -
3 spine devicemakers operating with a net gain in Q1
Spine devicemakers have shared their first quarter financial results this year in recent weeks. Some companies saw gains in sales, along with net gains after accounting for operational costs. -
5 spine devicemakers operating with a net loss in Q1
Spine devicemakers have shared their first quarter financial results this year in recent weeks. While many companies saw gains in sales, some also saw a net loss after accounting for operational costs. -
Aurora Spine's Q1 2024 sales grow 35.7%: 6 notes
Aurora Spine saw a 35.7% year-over-year increase in first quarter sales, according to financial results posted May 13. -
Meet the COOs of 5 top spine device companies
Leadership teams play a crucial role in running the top orthopedic and spine device companies nationwide. -
Medtronic in the headlines: 3 notes
Here are three updates on Medtronic that Becker's has reported on since April 24: -
Implanet earns FDA clearance for spine fixation system
Orthopedic technology company Implanet has earned FDA clearance for its hybrid fixation system, the Jazz Spinal System.
Page 7 of 199